Skip to main content
logo
Evofem Biosciences, Inc. (EVFM)
OTCMKTS · Delayed Price · Currency is USD
0.0076
-0.0004 (-5.00%)
At close: Aug 19, 2026

Evofem Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1111861
Market Cap Growth
-2.88%7.24%-12.38%-83.76%-87.13%-68.73%
Enterprise Value
60585044114149
Last Close Price
0.010.010.010.068.00704.06

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-4.39-0.03--
PS Ratio
0.060.060.060.070.477.43
PB Ratio
-0.01-0.02-0.02-0.02-0.11-0.61

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
3.352.882.612.436.7618.08
EV/EBITDA Ratio
-29.70----
EV/EBIT Ratio
-40.39----

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-0.66-0.79-0.69-0.70-0.99-1.16
Debt / EBITDA Ratio
-26.05----
Net Debt / Equity Ratio
-0.66-0.78-0.69-0.70-0.95-1.08
Net Debt / EBITDA Ratio
-12.2927.81-6.52-2.49-0.82-0.65
Net Debt / FCF Ratio
-113.89-27.25-11.76-4.83-0.97-0.72
Asset Turnover
1.650.921.131.020.500.11
Inventory Turnover
2.183.412.341.840.680.55
Quick Ratio
0.030.150.120.080.040.10
Current Ratio
0.070.180.170.130.140.22
Return on Assets (ROA)
-26.79%4.08%-27.94%-62.46%-155.38%-136.74%
Return on Capital Employed (ROCE)
5.80%-2.20%13.50%28.80%122.50%175.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-1464.10%32.49%-789.50%4136.67%-972.56%-334.95%
FCF Yield
-44.99%-165.93%-347.43%-700.55%-897.15%-244.21%
Buyback Yield / Dilution
-14.29%-7926.85%91.87%-211082.03%-567.40%-94.93%